AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 280: R69-R78, 2001;
0363-6119/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapoor, J. R.
Right arrow Articles by Sladek, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapoor, J. R.
Right arrow Articles by Sladek, C. D.
Vol. 280, Issue 1, R69-R78, January 2001

Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release

John R. Kapoor and Celia D. Sladek

Department of Physiology and Biophysics, Finch University of Health Sciences/ The Chicago Medical School, North Chicago, Illinois 60064

The supraoptic nuclei are innervated by the A1 neurons of the caudal ventrolateral medulla. Substances colocalized in the A1 terminals include norepinephrine (NE), substance P (SP), ATP, and neuropeptide Y (NPY). ATP, acting at P2x receptors, caused rapid and unsustained stimulation of vasopressin (VP) and oxytocin (OT) release from perifused explants of the hypothalamo-neurohypophysial system. SP elicited a concentration-dependent stimulation of VP and OT release that was large and sustained compared with other stimuli. ATP, but not phenylephrine (PE, alpha 1-adrenergic agonist), augmented the response to SP (1 µM). In contrast, NPY did not alter basal nor ATP-induced VP or OT release, but it did cause sustained potentiation of PE-induced VP and OT release. The Y1-agonist, [Leu31,Pro34]-NPY, increased VP and OT release, suggesting that the ineffectiveness of NPY reflects opposing actions at pre- and postsynaptic receptors. However, [Leu31,Pro34]-NPY did not potentiate hormone responses to ATP or PE. The differential responses to these colocalized neurotransmitters and neuropeptides illustrate the range of potential responses that stimulation of this pathway might elicit from supraoptic neurons.

norepinephrine; A1 neurons; neurohypophysis; supraoptic nucleus; hemodynamic regulation


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
A.-J. Li, Q. Wang, T. T. Dinh, and S. Ritter
Simultaneous Silencing of Npy and Dbh Expression in Hindbrain A1/C1 Catecholamine Cells Suppresses Glucoprivic Feeding
J. Neurosci., January 7, 2009; 29(1): 280 - 287.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. T. Theodosis, D. A. Poulain, and S. H. R. Oliet
Activity-Dependent Structural and Functional Plasticity of Astrocyte-Neuron Interactions
Physiol Rev, July 1, 2008; 88(3): 983 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. E. Howe, S. J. Somponpun, and C. D. Sladek
Role of Neurokinin 3 Receptors in Supraoptic Vasopressin and Oxytocin Neurons
J. Neurosci., November 10, 2004; 24(45): 10103 - 10110.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. E. Lohmeier
Neurohypophysial hormones
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R715 - R717.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
K. N Browning and R A. Travagli
Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus
J. Physiol., June 15, 2003; 549(3): 775 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. F. DiBona
Neuropeptide Y
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R635 - R636.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online